ARCHIVES

NCI’s Hawk To Lead Prevention Division At M.D. Anderson.

This article is from The Cancer Letter archive.

Vol. 33 No. 42 | November 16, 2007

Download PDF Visit The Full Archive

Related Articles

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Funding opportunities listed.

September 17, 2004

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

ASPO Honors Gritz.

May 25, 2001